Yuko Katayama Selected Research

Diabetes Complications

6/2017

Relationship between limited joint mobility of the hand and diabetic foot risk in patients with type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuko Katayama Research Topics

Disease

3	Fibrosis (Cirrhosis) 01/2022 - 01/2021
3	Asthma (Bronchial Asthma) 02/2017 - 08/2010
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 01/2021
2	Neoplasms (Cancer) 02/2021 - 11/2016
2	Neuroblastoma 12/2015 - 08/2003
1	Hepatocellular Carcinoma (Hepatoma) 02/2022
1	Type 2 Diabetes Mellitus (MODY) 02/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Fever (Fevers) 02/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2021
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 02/2021
1	Chronic Renal Insufficiency 01/2021
1	Obesity 01/2021
1	Inflammation (Inflammations) 01/2021
1	Albuminuria 01/2021
1	Hypercapnia 01/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 06/2017
1	Peripheral Arterial Disease 06/2017
1	Diabetes Complications 06/2017
1	Disease Progression 11/2016
1	Breast Neoplasms (Breast Cancer) 11/2016
1	Eosinophilia 04/2011
1	Human Influenza (Influenza) 10/2010
1	Pneumonia (Pneumonitis) 10/2010
1	Lung Injury 10/2010
1	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2010
1	Subacute Sclerosing Panencephalitis (SSPE) 08/2003
1	Vesicular Stomatitis 08/2003

Drug/Important Bio-Agent (IBA)

2	N- (((3S)- 6- ((4- carbamimidamidobenzoyl)oxy)- 2,3- dihydro- 1- benzofuran- 3- yl)acetyl)- L- aspartic acid hydrateIBA 01/2021 - 01/2021
2	EnteropeptidaseIBA 01/2021 - 01/2021
2	Therapeutic UsesIBA 01/2021 - 08/2010
2	Immunoglobulin E (IgE)IBA 02/2017 - 04/2011
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2022
1	Pyruvic Acid (Pyruvate)IBA 02/2022
1	Glucose (Dextrose)FDA LinkGeneric 02/2022
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 02/2022
1	SaltsIBA 01/2022
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 02/2021
1	Cysteine (L-Cysteine)FDA Link 01/2021
1	Serine Proteases (Serine Protease)IBA 01/2021
1	Methionine (L-Methionine)FDA Link 01/2021
1	Carbon DioxideIBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	Serum AlbuminIBA 01/2018
1	NAD (NADH)IBA 06/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2017
1	Hormones (Hormone)IBA 11/2016
1	Androgen Receptors (Androgen Receptor)IBA 11/2016
1	Estrogen ReceptorsIBA 11/2016
1	Gonadal Steroid Hormones (Sex Hormones)IBA 11/2016
1	Testosterone (Sustanon)FDA Link 11/2016
1	UbiquitinIBA 12/2015
1	HydrolasesIBA 12/2015
1	Salmeterol Xinafoate (Serevent)FDA Link 12/2012
1	Fluticasone (Cutivate)FDA LinkGeneric 12/2012
1	Formoterol Fumarate (Oxis)FDA Link 12/2012
1	Budesonide (Pulmicort)FDA LinkGeneric 12/2012
1	VaccinesIBA 10/2010
1	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2010
1	Omalizumab (Xolair)FDA Link 08/2010
1	Glycoproteins (Glycoprotein)IBA 08/2003
1	Monoclonal AntibodiesIBA 08/2003

Therapy/Procedure

1	Nephrectomy 01/2022
1	Drug Therapy (Chemotherapy) 02/2021
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2018
1	Hysterectomy 11/2016
1	Sex Reassignment Surgery 11/2016
1	Salpingo-oophorectomy 11/2016
1	Mastectomy (Mammectomy) 11/2016